Mirae Asset Global Investments Co., Ltd. Nautilus Biotechnology, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $22.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 4,536 shares of NAUT stock, worth $7,847. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,536
Previous 3,740
21.28%
Holding current value
$7,847
Previous $8,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NAUT
# of Institutions
86Shares Held
64.3MCall Options Held
1.9KPut Options Held
100-
Ah Equity Partners Bio Ii, L.L.C. Menlo Park, CA16.3MShares$28.2 Million24.08% of portfolio
-
Perceptive Advisors LLC New York, NY12.6MShares$21.8 Million0.94% of portfolio
-
Cercano Management LLC Bellevue, WA7.17MShares$12.4 Million0.51% of portfolio
-
Madrona Venture Group, LLC6.02MShares$10.4 Million23.0% of portfolio
-
Black Rock Inc. New York, NY3.83MShares$6.62 Million0.0% of portfolio
About Nautilus Biotechnology, Inc.
- Ticker NAUT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,663,000
- Market Cap $216M
- Description
- Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...